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PUBLICATIONS on ureteral complications in renaltransplantation usually only discuss technical factors.
Very few investigators have assessed the role of other risk
factors in the development of this problem. Some research-
ers have pointed out the role of rejection in the develop-
ment of ureteral stenosis. However, they neither character-
ize the lesions nor propose any etiologic pathogenic
mechanism,1–3 or believe that the ureteral lesions are a
consequence of ischemia from rejection of the renal ves-
sels.4,5 Even recent studies from renowned investigators
ignore the role of rejection in the development of ureteral
complications.6–8
PATIENTS AND METHODS
We analyzed 1000 consecutive renal transplants performed at our
institution from July 1980 to February 2001, regarding the occur-
rence of ureteral complications. A database was constructed from
the records of all donors and recipients. We evaluated parameters
of the donor (age, cause of death, weight, ventilation time, harvest-
ing technique, perfusion solution, cold ischemia time), the recipient
(age, time on dialysis, associated pathology, weight, etiology of
renal failure, HLA mismatches, ureteral implantation technique,
ureteral length, duration of surgery), and the transplant course
(immunosuppression, delayed graft function [DGF], acute rejec-
tion [AR] episodes, cyclosporine [CyA] dose at 1 year). The
occurrence of ureteral complications was correlated with the
development of chronic graft dysfunction (CGD) and with graft
survival. The ureteral fragments retrieved during revision surgeries
were studied for the presence of lesions suggestive of rejection. A
multiple logistic regression analysis was used to assess the adjusted
effect of all donor, recipient, and transplant parameters on ureteral
complications. Univariate analysis was evaluated with the Fisher
Exact Test. The Kaplan-Meier method was employed to estimate
graft survival and the log-rank test to compare survival rates
between the two groups (with or without ureteral complications).
For all tests a P value .05 was considered significant (two-tailed).
RESULTS
Fifty-six patients (5.6%) developed ureteral complications,
including 31 stenoses and 25 fistulae. One patient with a
fistula died. The patient, a 60-year-old man with coronary
disease, presented with a fistula on the fourth day and
underwent ureteric reimplantation, but he developed car-
diorespiratory failure that was complicated by sepsis. The
kidney graft was removed on the 23rd day, but he died the
next day. All other ureteral complications were successfully
treated; no other patient or graft was lost as a direct
consequence of a ureteral complication. Twenty-four of 25
fistulae presented in the first month after transplant,
whereas for the 31 stenoses the average time for presenta-
tion was 20.5 months, ranging from 10 days to 11 years.
None of the donor factors were significantly associated
with the occurrence of ureteral complications. Without
reaching statistical significance, some factors were theoret-
ically even more favorable among the cases that developed
complications. The global cold ischemia time for the 1000
transplants was 20.7 hours, versus 19.6 and 19.9 hours in
cases that developed stenoses and fistulae, respectively.
Similarly, no recipient factor was significantly associated
with the development of ureteral complications. The low
number of ureteroureterostomies performed does not allow
any conclusion to be drawn from the relatively high number
of complications observed with this technique (Table 1). In
the absence of a measurement, the probable ureteral length
was calculated from the site of placement of the arterial
vascular anastomosis, assuming that the ureteral segment
was long when the graft was anastomosed on the aorta,
medium when anastomosed on the common iliac, and short
when on the external or internal iliac vessels. Only 977 cases
of bladder implantation were considered, the psoic bladder
case being excluded. The analysis did not reveal statistically
significant association between ureteral length and the
development of ureteral complications (Table 2).
The development of ureteral complications was signifi-
cantly associated with the occurrence of CGD (P  .019).
Furthermore, the association with DGF was close to statis-
tical significance (P  .054), an association that was statis-
tically significant when the stenoses were considered sepa-
rately (P  .000) (Table 2).
Actuarial graft survivals at 1, 3, 5, 10, and 15 years were
96%, 86%, 72%, 62%, and 40%, respectively, for the group
with ureteral complications, and 91%, 85%, 78%, 63%, and
54%, respectively, for the group without, a difference that
was not statistically significant.
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For comparisons between fistulae and stenoses, we stud-
ied the same donor, recipient, and transplant parameters.
The small number of cases limited the analysis, but we
found that many more stenoses than fistulae presented with
a history of DGF, a difference that was statistically signifi-
cant (P  .000). Similarly, more stenoses than fistulae were
associated with a history of AR episodes, a difference that
was not statistically significant (P .098) (Table 3). Only six
ureteral fragments from surgical revision of complications
were available for histological study: three from stenosis
cases and three from fistula cases. While the three fistula
cases showed only nonspecific inflammatory infiltrates, all
fragments from the stenotic ureters presented lesions sug-
gestive of AR, including epithelial permeation and intersti-
tial infiltration by T lymphocytes and arterial endothelialitis
with intimal fibrosis.
DISCUSSION
The incidence of ureteral complications, which varies be-
tween 3% and 20%, has not changed substantially over the
last decades. Reports on surgical complications of kidney
transplantation only seldom address the hypothetical etio-
logical role of immunological factors in the study of risk
factors. The correlation that we observed between ureteral
complications and evolution to CGD may signify that some
ureteral complications result from rejection phenomena.
These same episodes occurring at the kidney level may
favor the development of CGD. Conversely, the resem-
blance between the kidney lesions secondary to ureteral
obstruction and the lesions of CGD suggest another hy-
pothesis. Recent studies of CGD and obstructive nephrop-
athy in rat models demonstrate that both conditions are
correlated with macrophage infiltration, cytokine liberation,
tubular atrophy, and interstitial fibrosis.9–12 This finding
raises the question whether ureteral stenoses, even incipient
ones, contribute to chronic graft rejection processes.8
CONCLUSION
We identified a statistically significant relationship between
ureteral complications and DGF and CGD. Graft survival
in the patients with ureteral complications was the same as
in patients without these complications. The early appear-
ance of fistula suggests a technical or ischemic origin,
whereas the late development of stenosis may be due to
rejection episodes, according to our histopathological findings.
REFERENCES
1. Bewick M, Collins REC, Saxton HM, et al: Br J Urol 46:493,
1974
2. Mundy AR, Podesta ML, Bewick M, et al: Br J Urol 53:397,
1981
3. Kinnaert P, Hall M, Janssen F, et al: J Urol 133:17, 1985
4. Bishop MC: BMJ 285:394, 1982
5. Schweizer RT, Bartus SA, Kahn CS: J Urol 117:125, 1977
6. Shoskes DA, Hanbury D, Cranston D, et al: J Urol 153:18,
1995
7. Kahan BD, Ponticelli C: Principles and Practice of Renal
Transplantation. London: Martin Dunitz Ltd; 2000, p xxx
8. Berger PM, Diamond JR: J Nephrol 11:20, 1998
9. Van Goor H, Ding G, Kees-Folts D, et al: Lab Invest 71:456,
1994
10. Diamond JR: Am J Kidney Dis 26:133, 1995
11. Crisman JM, Richards LL, Valach DP, et al: Exp Nephrol
9:241, 2001
12. Song E, Zou H, Yao Y, et al: Kidney Int 61:676, 2002
Table 1. Correlation Between Technical Factors and
Development of Ureteral Complications
Ureteral Complications
Implantation Technique
(n  1000) Fistulae Stenoses
Fistulae 
Stenoses/Total
LG  external stent (594) 17 19 6.0%
LG  “JJ” stent (248) 5 5 4.0%
LG without stent (28) – 1 3.6%
Politano–Leadbetter (88) 1 3 4.5%
Barry–Hatch (17) – 1 5.9%
Ureteroureterostomy (17) 2 2 23.5%
Other (8) – – –
Ureteral Length* (n  977)
Long (7) 1 – 14.2%
Medium (828) 25 16 4.9%
Short (142) 3 7 7.0%
LG, Lich-Gregoir.
*Presumed after the arterial anastomoses placement.
Table 2. Correlation Between Ureteral Complications and Risk
Factors






Chronic dysfunction (n  918)
Yes 8.6% .019 1.960 1.107–3.470
No 4.7%
DGF (n  971)
Yes 9.1% .054 1.845 0.982–3.468
No 5.1%
Stenoses (n  31)
DGF (n  971)
Yes 7.8% .000 3.549 1.686–7.472
No 2.3%
DGF, delayed graft function.
Table 3. Comparison Between Fistulae and Stenoses
Ureteral Complications (n  56)
Factors Fistulae Stenoses P Value
DGF
Yes 8% 38.7% .000
No 92% 61.3%
Acute Rejection
Yes 20.8% 41.9% .098
No 79.2% 58.1%
DGF, delayed graft function.
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